ArticleScientific reports2025
Safety and feasibility of directional coronary atherectomy with transradial approach using an 8Fr sheathless guiding catheter.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to assess the safety and feasibility of the transradial approach (TRA) using the 8Fr sheathless guiding catheter (GC) in directional coronary atherectomy (DCA). This retrospective analysis included all consecutive patients who underwent percutaneous coronary intervention with DCA from April 2021 to March 2024 in three cardiovascular centers. During the study period, 194 DCA procedures were performed. Of these, 51 included the TRA using an 8Fr sheathless guiding system, whereas the remaining 143 included the conventional transfemoral approach (TFA) system. Primary outcomes were the vascular access site complication (VASC), defined as a bleeding complication in the perioperative period, retroperitoneal hematoma, pseudoaneurysm, large hematoma around the puncture site, or access vessel occlusion rate, and technical success rates, defined as delivery of the DCA catheter to the target lesion and plaque debulking to < 60% of the %plaque area. Although there were some bias such as the lower lesion complexity in the TRA group, the VASC rate was significantly lower in the TRA group than in the TFA group (p = 0.02) and both approaches had > 80% technical success rates. In conclusion, DCA with TRA using an 8Fr sheathless GC may be a safe and feasible method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.